Jabra Enhance Select 50R vs Otofonix Groove

The Jabra Enhance Select 50R is a premium-priced OTC hearing aid at $1,195, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This behind-the-ear device ranks #29 of 65 OTC hearing aids tested, placing it in the top 43% of its category. In our testing, the Select 50R demonstrates notable strengths in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.75 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during typical wear. Music streaming also performs above average at 2.8/5, though this remains mixed in absolute terms. The device shows limitations in challenging listening situations. Speech in noise scores just 1.0/5, falling 0.48 points below the category average—a meaningful weakness for those who frequently encounter noisy environments. Own-voice comfort is mixed at 2.5/5, essentially matching the category average. At this price point, shoppers should note that several competitors deliver stronger overall performance. The Jabra Enhance Select 500 scores 4.16/5, while the Lucid Tala and Audicus Omni 2 both exceed 4.5/5. For those prioritizing value, devices like the Sony CRE-C20 offer similar sound performance at lower prices. The Select 50R is best suited for users who primarily need help hearing in quieter settings and value Jabra's ecosystem and reliable feedback control.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.